Phibro animal health corp (PAHC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13
OPERATING ACTIVITIES
Net income

13,501

11,894

2,515

8,802

14,849

14,748

16,314

22,119

19,840

7,032

15,892

15,378

23,643

13,417

12,177

15,220

18,577

30,178

18,753

10,404

16,696

14,248

18,932

-17,642

6,370

2,302

5,843

Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization

8,248

8,148

7,781

7,157

6,875

6,841

6,691

6,917

6,751

6,631

6,644

6,397

6,842

6,444

6,318

6,774

5,856

5,393

5,429

5,654

5,356

5,241

5,353

5,838

5,122

5,292

5,201

Amortization of debt issuance costs and debt discount

220

221

221

220

221

220

221

221

221

220

221

254

253

255

253

255

250

242

242

242

242

241

242

266

396

395

391

Stock-based compensation

565

564

565

565

565

564

565

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related costs of goods sold

0

0

280

-

-

-

-

-

0

1,422

249

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related accrued compensation

-

-

-

-

-

-

-

-

160

487

437

-

420

420

420

420

420

420

420

-

-

-

-

-

-

-

-

Acquisition-related accrued interest

68

79

53

-

-

-

0

-

290

252

253

-

459

462

393

393

394

344

345

-

-

-

-

-

-

-

-

Deferred income taxes

-714

87

-652

-1,847

1,607

608

-473

-1,624

2,288

4,955

770

-4,096

332

2,030

1,706

873

-1,502

-21,653

38

1,430

3,155

-370

546

628

769

-659

551

Foreign currency (gains) losses, net

-808

1,792

-1,660

1,609

302

-2,993

2,981

-652

1,298

334

-345

69

1,091

-196

-97

2,090

2,845

-2,644

5,434

-1,211

3,541

730

316

-2,979

284

1,093

173

Other

-246

-258

-116

-502

-267

1,337

-266

-460

-303

-205

-213

-219

-236

-223

-87

-68

-137

-96

-53

-101

19

-76

97

164

183

153

38

Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable, net

8,897

1,159

-14,065

5,755

9,018

8,821

85

12,196

-5,371

-3,311

8,386

12,785

-11,603

5,489

-3,906

6,530

-329

1,288

5,597

-5,002

3,439

4,858

-1,418

5,914

4,389

9,202

-4,822

Inventories, net

-3,172

-12,498

9,086

7,511

-2,807

6,774

9,504

2,563

10,884

5,649

5,196

-1,561

3,146

-2,473

-4,544

-3,383

7,028

7,325

5,469

12,621

-2,548

1,782

7,499

-616

1,331

906

1,565

Other current assets

-459

1,487

813

3,062

495

-38

3,654

-1,901

-2,984

293

4,458

413

3,518

-3,349

2,430

-1,448

682

-1,261

1,570

-5,967

3,108

-1,085

-3,472

-1,137

744

-2,225

2,649

Other assets

-26

324

1,071

152

1,013

-495

-371

225

591

-332

-332

1,048

-56

858

-346

4,777

-1,573

2,899

444

4,341

-4

-69

-32

-6,523

1,263

114

43

Accounts payable

9,949

-2,274

-11,834

7,717

-794

2,375

2,794

-4,338

-689

3,821

3,652

3,269

-1,721

337

-5,004

8,470

-6,873

-1,832

-3,010

5,995

800

-7,431

5,432

-1,070

293

7,587

-5,128

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,920

-6,913

6,947

-6,927

Accrued expenses and other liabilities

-701

5,378

-7,370

9,852

85

3,406

-9,245

-1,907

-1,940

9,898

-6,165

2,803

2,709

1,316

-1,357

1,720

-5,185

2,417

-6,150

2,020

1,823

2,614

-10,155

-6,085

1,823

1,811

-853

Net cash provided (used) by operating activities

26,950

32,091

-3,570

14,879

15,654

15,356

1,280

10,109

22,806

32,290

4,803

13,575

37,077

26,277

21,456

26,592

5,022

7,998

-2,394

21,862

21,079

8,403

17,360

-17,342

234

16,618

-222

Capital expenditures

7,854

8,440

7,675

10,117

7,657

6,068

6,049

5,529

4,168

3,853

4,998

5,503

4,813

4,653

5,911

7,704

10,995

9,559

8,094

6,955

5,375

3,753

3,975

5,598

4,483

5,543

4,222

Business acquisitions

0

-11

54,560

0

0

0

9,838

0

0

3,438

11,562

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

294

749

296

140

291

-289

262

-508

856

444

272

-729

1,590

226

-25

5

121

-17

-246

27

4,811

-794

-15

-324

-101

-8

-1

Net cash provided (used) by investing activities

-14,148

-34,178

-62,531

14,743

-7,948

-4,779

-16,149

-10,021

-23,024

-34,735

-16,832

-4,774

-6,403

-4,879

-5,886

-7,739

-57,662

-9,542

-7,848

-12,359

-15,186

-2,959

-3,960

-5,274

-4,382

-5,535

-4,221

Revolving credit facility borrowings

39,000

36,000

119,000

56,000

54,000

32,000

71,000

59,130

56,000

48,000

61,870

112,000

45,500

39,000

34,000

33,000

122,000

45,000

55,500

-

-

-

-

30,500

69,500

33,000

42,500

Revolving credit facility repayments

42,000

55,000

47,000

56,000

46,000

29,000

56,000

54,630

61,500

62,000

41,870

77,000

64,000

52,500

41,000

46,000

60,000

45,500

38,000

-

-

-

-

73,000

59,000

49,000

28,500

Payments of long-term debt and other

-3,125

-3,146

-3,215

22,153

-3,145

-3,144

-3,215

1,582

1,583

1,584

1,652

282,025

726

2,047

729

731

732

1,732

734

732

1,754

743

861

333,334

862

1,161

17

Issuance of acquisition note payable

-

-

-

-

0

0

3,775

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from common shares issued

-

-

-

0

793

130

211

407

1,592

214

3,486

-

-

-

-

52

1,887

1,385

693

-

-

-

-

-

-

-

-

Dividends paid

4,854

4,855

4,854

4,854

4,855

4,846

4,037

4,036

4,029

4,019

3,989

3,986

3,959

3,941

3,941

3,941

3,940

3,917

3,910

3,903

3,901

3,895

3,896

-

-

-

-

Net cash provided (used) by financing activities

-10,979

-27,001

63,931

-7,999

-2,982

-4,860

11,734

-711

-9,520

-19,389

17,845

-1,975

-20,715

-19,378

-11,670

-17,620

59,215

-4,764

13,549

-917

-5,197

-4,480

-4,757

23,319

-15,362

-17,161

13,983

Effect of exchange rate changes on cash

-1,255

375

-510

74

-184

-241

-173

-762

106

-78

198

-53

131

-215

-90

147

278

-137

-706

-174

-581

-24

-715

139

15

-299

-58

Net increase (decrease) in cash and cash equivalents

568

-28,713

-2,680

21,697

4,540

5,476

-3,308

-1,385

-9,632

-21,912

6,014

6,773

10,090

1,805

3,810

1,380

6,853

-6,445

2,601

8,412

115

940

7,928

842

-19,495

-6,377

9,482

Non-cash investing and financing activities
Capital/leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,315